Skip to content
Peptigraph home

AOD-9604

HGH fragment analog. AOD-9604 is Not FDA approved · research chemical; research-chemical versions are not the approved drug.

Also called:AOD
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Animal evidence, 2 of 4
StatusNot FDA approved · research chemicalProhibited by WADA (S2.2.3)Full legal history

Key facts

How we verify
Class
HGH fragment analog
Also called
AOD
Vial sizes sold
2 mg, 5 mg, 10 mg
Community-reported sizes
Half-life
Not found
No published half-life found (PubMed search, 2 Oct 2026)
FDA status
Not FDA approved · research chemical
No approved product found
WADA
Prohibited (S2.2.3)
In and out of competition
Everything on AOD-9604

AOD-9604 guides

DosageDoses used in published studies, with the source for each.Side effectsWhat labels and studies report, and what is unknown.CalculatorVial, water and dose to syringe units.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.5 mg vialConcentration and unit tables for the 5 mg size.For weight lossWhat research says about AOD-9604 for weight loss.
Vial and dose sizes
2 mg vial10 mg vial

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

AOD-9604: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Weight lossNot in our ledgerNot in our ledger3Animal evidence, 2 of 4International journal of obesity and related metabolic disorders 2001, PMID 11673763

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

Compared with

AOD-9604vsTesamorelinHGH fragment analog next to ghrh analog: evidence, dosing and legal status side by side.FDA approved (Egrifta)Read the comparison →AOD-9604vsMOTS-cHGH fragment analog next to mitochondrial-derived peptide: evidence, dosing and legal status side by side.PCAC voted 7–5 for 503A (Jul 2026)Read the comparison →AOD-9604vs5-Amino-1MQHGH fragment analog next to nnmt inhibitor (not a peptide): evidence, dosing and legal status side by side.Not FDA approved · research chemicalRead the comparison →AOD-9604vsRetatrutideHGH fragment analog next to GLP-1 / GIP / glucagon triple agonist: evidence, dosing and legal status side by side.Investigational · phase 3Read the comparison →

Common stacks

AOD-9604 is often sold pre-mixed or combined with other peptides. No controlled study has tested these combinations; the pages below cover the math and what each part has been studied for.

AOD-9604 + TesamorelinAOD-9604 + TirzepatideAOD-9604 + CJC-1295 + IpamorelinAOD-9604 + Retatrutide

Common questions

Is AOD-9604 FDA approved?

AOD-9604 is Not FDA approved · research chemical. Products sold as research chemicals are not the approved drug and are not checked by the FDA.

Is AOD-9604 banned in sport?

Yes. Prohibited by WADA (S2.2.3), so it is prohibited at all times for tested athletes.

How much water goes in a 10 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

Sources

  1. 1US search volume and year-over-year trend, Google Keyword Planner export (Jun–Aug 2026 vs 2025)Peptigraph research · 2026peptigraph.com/methodology/Accessed 1 Oct 2026
  2. 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  3. 3United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "aod-9604" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  4. 4US compounding: AOD-9604 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  5. 5Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001PMID 11673763Accessed 2 Oct 2026
  6. 6Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.Annals of clinical and laboratory science · 2015PMID 26275694Accessed 2 Oct 2026
  7. 7PubMed search: AOD9604[tiab] OR "AOD-9604"[tiab] OR "AOD 9604"[tiab] (22 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.